Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.

Haining WN, Davies J, Kanzler H, Drury L, Brenn T, Evans J, Angelosanto J, Rivoli S, Russell K, George S, Sims P, Neuberg D, Li X, Kutok J, Morgan J, Wen P, Demetri G, Coffman RL, Nadler LM.

Clin Cancer Res. 2008 Sep 1;14(17):5626-34. doi: 10.1158/1078-0432.CCR-08-0526.

PMID:
18765557
[PubMed - indexed for MEDLINE]
Free Article
2.

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.

Manegold C, Gravenor D, Woytowitz D, Mezger J, Hirsh V, Albert G, Al-Adhami M, Readett D, Krieg AM, Leichman CG.

J Clin Oncol. 2008 Aug 20;26(24):3979-86. doi: 10.1200/JCO.2007.12.5807.

PMID:
18711188
[PubMed - indexed for MEDLINE]
Free Article
3.

Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept.

Friedberg J, Jacobsen E, Neuberg D, Kutok J, Munoz O, Boussiotis V, Reynolds H, Fisher D, Szot A, Van Den Abbeele A, Freedman A.

Leuk Lymphoma. 2008 May;49(5):902-9. doi: 10.1080/10428190801950033.

PMID:
18464109
[PubMed - indexed for MEDLINE]
4.

Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study.

Cartron G, Zhao-Yang L, Baudard M, Kanouni T, Rouillé V, Quittet P, Klein B, Rossi JF.

J Clin Oncol. 2008 Jun 1;26(16):2725-31. doi: 10.1200/JCO.2007.13.7729. Epub 2008 Apr 21.

PMID:
18427151
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.

LaCasce AS, Freedman AS.

Semin Hematol. 2008 Apr;45(2):85-9. doi: 10.1053/j.seminhematol.2008.02.004. Review.

PMID:
18381102
[PubMed - indexed for MEDLINE]
6.

Monoclonal antibodies in lymphoma: the first decade.

Link BK, Friedberg JW.

Semin Hematol. 2008 Apr;45(2):71-4. doi: 10.1053/j.seminhematol.2008.02.005.

PMID:
18381100
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.

Krieg AM.

Oncogene. 2008 Jan 7;27(2):161-7. doi: 10.1038/sj.onc.1210911. Review.

PMID:
18176597
[PubMed - indexed for MEDLINE]
8.

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.

Exp Hematol. 2008 Jan;36(1):69-77. Epub 2007 Oct 23.

PMID:
17959301
[PubMed - indexed for MEDLINE]
9.

Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.

Leonard JP, Link BK, Emmanouilides C, Gregory SA, Weisdorf D, Andrey J, Hainsworth J, Sparano JA, Tsai DE, Horning S, Krieg AM, Weiner GJ.

Clin Cancer Res. 2007 Oct 15;13(20):6168-74.

PMID:
17947483
[PubMed - indexed for MEDLINE]
Free Article
10.

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.

Li J, Song W, Czerwinski DK, Varghese B, Uematsu S, Akira S, Krieg AM, Levy R.

J Immunol. 2007 Aug 15;179(4):2493-500.

PMID:
17675511
[PubMed - indexed for MEDLINE]
Free Article
11.

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Wahlin BE, Sander B, Christensson B, Kimby E.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):388-97.

PMID:
17255259
[PubMed - indexed for MEDLINE]
Free Article
12.

CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.

Ponzio NM, Cutro S, Hu J, Marzouk A, Marshall JD.

Int Immunopharmacol. 2006 Dec 20;6(13-14):2057-68. Epub 2006 Sep 18.

PMID:
17161362
[PubMed - indexed for MEDLINE]
13.

Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Alvaro T, Lejeune M, Salvadó MT, Lopez C, Jaén J, Bosch R, Pons LE.

J Clin Oncol. 2006 Dec 1;24(34):5350-7.

PMID:
17135637
[PubMed - indexed for MEDLINE]
Free Article
14.

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides.

Fujii H, Trudeau JD, Teachey DT, Fish JD, Grupp SA, Schultz KR, Reid GS.

Blood. 2007 Mar 1;109(5):2008-13. Epub 2006 Oct 26.

PMID:
17068155
[PubMed - indexed for MEDLINE]
Free Article
15.

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I.

Clin Immunol. 2007 Feb;122(2):139-45. Epub 2006 Sep 27.

PMID:
17008130
[PubMed - indexed for MEDLINE]
16.

Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.

Link BK, Ballas ZK, Weisdorf D, Wooldridge JE, Bossler AD, Shannon M, Rasmussen WL, Krieg AM, Weiner GJ.

J Immunother. 2006 Sep-Oct;29(5):558-68.

PMID:
16971811
[PubMed - indexed for MEDLINE]
17.

Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma.

Friedberg JW, Freedman AS.

Curr Treat Options Oncol. 2006 Jul;7(4):276-84. Review.

PMID:
16916488
[PubMed - indexed for MEDLINE]
18.

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, Montserrat E, Campo E, Banham AH.

Blood. 2006 Nov 1;108(9):2957-64. Epub 2006 Jul 6.

PMID:
16825494
[PubMed - indexed for MEDLINE]
Free Article
19.

Pathogen recognition and innate immunity.

Akira S, Uematsu S, Takeuchi O.

Cell. 2006 Feb 24;124(4):783-801. Review.

PMID:
16497588
[PubMed - indexed for MEDLINE]
Free Article
20.

Unique toxicities and resistance mechanisms associated with monoclonal antibody therapy.

Friedberg JW.

Hematology Am Soc Hematol Educ Program. 2005:329-34.

PMID:
16304399
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk